Andrea I. Havasi, MD

Andrea Havasi is an Assistant Professor of Medicine at Boston University. She is board certified in internal medicine and nephrology. She received her medical degree from Semmelweis School of Medicine, Budapest, Hungary. She completed residency from Bridgeport Hospital-Yale Health Care, Bridgeport CT and renal fellowship at Boston University School of Medicine, Boston Massachusetts.

She is the recipient of the American Heart Association Scientist Development Grant and NIH K08 award. She has a special clinical and research interest in onco-nephrology and amyloidosis, and is a faculty in BU’s Amyloidosis Center.

Dr. Havasi is a Co-Director of BU’s Mitochondria Affinity Research Collaborative, and Director of Nephrology Fellowship Program’s Onco-nephrology / Amyloidosis Pathway. Her clinical roles include attending time on the consult and dialysis/transplant services and weekly outpatient clinics (amyloidosis, chronic kidney disease, hemodialysis and peritoneal dialysis clinics).

Representative Publications:

Long-term Outcome of Kidney Transplantation in AL Amyloidosis.

Predictive Value of the New Renal Response Criteria in Al Amyloidosis Treated With High Dose Melphalan and Stem Cell Transplantation.
Nucleophosmin Phosphorylation as a Diagnostic and Therapeutic Target for Ischemic AKI.
Correction for Wang et al., “Nucleophosmin, a Critical Bax Cofactor in Ischemia-Induced Cell Death”.
High-Dose Melphalan and Stem Cell Transplantation in Patients on Dialysis Due to Immunoglobulin Light-Chain Amyloidosis and Monoclonal Immunoglobulin Deposition Disease.